Teva Pharmaceutical Industries Ltd. (TEVJF)
Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine
Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine
Best Anker Headphones for Every Budget in 2025
Best Bagless Vacuum Models for Powerful Home Cleaning in 2025
Best ASUS Monitors in 2025
Best 4K HDR Monitors for Professional Gamers and Designers
Best 48, 49, and 50 Inch TVs for Your Home (2025)
Galapagos Appoints Aaron Cox as Chief Financial Officer
Bausch Health Notification
Bausch Health Notification
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer
Cordlife Group Limited - Announcement
Q & M Dental Group (Singapore) Limited - Announcement
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
Immutep Announces Positive Update from Phase I Study of IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases